D
Entrada Therapeutics, Inc. TRDA
$6.17 $0.305.11% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 1.95M 20.56M 37.40M 19.57M 94.69M
Total Other Revenue -- -- -- -- --
Total Revenue 1.95M 20.56M 37.40M 19.57M 94.69M
Cost of Revenue 37.88M 32.07M 33.41M 31.26M 32.04M
Gross Profit -35.93M -11.52M 3.99M -11.69M 62.66M
SG&A Expenses 10.92M 10.27M 9.86M 9.97M 9.24M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 48.80M 42.35M 43.27M 41.23M 41.27M
Operating Income -46.85M -21.79M -5.87M -21.66M 53.42M
Income Before Tax -42.93M -17.35M -739.00K -15.89M 57.79M
Income Tax Expenses 178.00K -- -1.87M -1.86M 2.76M
Earnings from Continuing Operations -43.10M -17.35M 1.13M -14.03M 55.03M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -43.10M -17.35M 1.13M -14.03M 55.03M
EBIT -46.85M -21.79M -5.87M -21.66M 53.42M
EBITDA -45.82M -20.84M -4.88M -20.72M 54.33M
EPS Basic -1.04 -0.42 0.03 -0.35 1.61
Normalized Basic EPS -0.65 -0.26 -0.01 -0.24 1.06
EPS Diluted -1.04 -0.42 0.02 -0.35 1.55
Normalized Diluted EPS -0.65 -0.26 -0.01 -0.24 1.02
Average Basic Shares Outstanding 41.34M 41.07M 40.84M 40.63M 34.18M
Average Diluted Shares Outstanding 41.34M 41.07M 43.05M 40.63M 35.51M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --